After an initial run of our Best Dividend Stocks screener, designed to surface quality names that can sustain a healthy payout, Amdocs Ltd (NASDAQ:DOX) emerges as a strong candidate. The strategy behind this screen is to avoid the trap of chasing the highest dividend yield without considering the fundamentals. By filtering for a minimum ChartMill Dividend Rating of 7, while also requiring a Health Rating of 5 and a Profitability Rating of 5, we aim to find companies that not only pay a generous dividend but also have the financial stability to keep doing so. The goal is to sidestep value traps where a high yield is merely a symptom of a plunging stock price. Amdocs not only clears these hurdles but stands out in several key areas, particularly its valuation, which makes the high dividend yield even more attractive.
Dividend Profile: High Yield with a Track Record
The most immediate draw for a dividend investor is the yield itself. Amdocs provides a yearly dividend yield of 4.42%, which is significantly higher than the S&P 500 average of 1.83% and an industry average of 1.68%. In fact, it pays more than 90.91% of its peers in the IT Services industry. However, as our screening methodology emphasizes, a high yield requires deeper investigation.
The screen's criteria for a minimum Dividend Rating of 7 ensures we look beyond a simple snapshot. Amdocs earns a top-tier Dividend Rating of 8 out of 10, supported by a strong history. The company has been paying a dividend for at least 10 years and has not reduced it in that time. Furthermore, the dividend has been growing at an annual rate of 10.47%, a strong signal of management's confidence in the company's cash generation capabilities.
However, no dividend is without its risks. The payout ratio stands at 43.06% of net income. While this is not alarming, it is on the higher side. More importantly, the report notes that the dividend is growing faster than earnings, which is a clear red flag for long-term sustainability. This is a key aspect our screening methodology flags for further investor scrutiny. A current yield that looks cheap due to a stock price decline (-20.61% in the last three months) also warrants a closer look at the underlying business health.
Profitability and Health: The Supporting Cast
The screen's filters for decent profitability (Rating >= 5) and health (Rating >= 5) are crucial to support the dividend story. A high yield is meaningless if the company is losing money or taking on too much debt to pay shareholders.
- Profitability (Rating: 8/10): Amdocs demonstrates very strong profitability. Its Return on Invested Capital (ROIC) of 14.12% beats 86.36% of its industry peers. The Operating Margin of 17.74% is in the top 10% of the industry. All basic checks are positive: the company has been profitable each year for the past five years and has had positive operating cash flow in each of those years. This consistent cash generation is the fuel for the dividend.
- Health (Rating: 6/10): The health rating is the weakest link, but it still passes the screen's threshold. The company exhibits excellent solvency, with a low Debt/Equity ratio of 0.19 and a Debt to Free Cash Flow ratio of 1.32, meaning it could pay off all its debt in just over a year with its free cash flow. The primary concern lies in liquidity. Both the Current Ratio (0.98) and Quick Ratio (0.98) are below 1.0, a level that often signals potential difficulty in meeting short-term obligations. The report itself offers a critical nuance here: “The current and quick ratio evaluation for DOX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarily indicate liquidity issues and need to be evaluated against the specifics of the business.” Essentially, for a company with strong cash flow and low debt, a current ratio just under 1.0 may be manageable but is still a point to monitor.
Valuation: The Strong Case for Value and Yield
What truly sets Amdocs apart is its valuation, which is where the strategy against chasing yield in a falling market becomes most relevant. The stock appears significantly undervalued on a pure earnings basis.
- Price/Earnings (P/E) Ratio: 7.21 – This is very low compared to the S&P 500 average of 26.74 and cheaper than 81.82% of its industry peers.
- Price/Forward Earnings Ratio: 6.29 – Even looking at future earnings, the valuation remains extremely attractive.
- Enterprise Value/EBITDA: Also indicates cheapness compared to the industry.
For a dividend investor, this valuation is a strong double-edged sword. It suggests that the high yield (4.42%) is not solely due to a recent price crash, but rather that the stock was already trading at a depressed valuation. This provides a margin of safety, as the yield can remain attractive even if the price stabilizes or recovers. The strong profitability rating (8/10) partially explains the market's skepticism might be overdone, as the report notes, "An outstanding profitability rating, which may justify a higher PE ratio." This combination of a high dividend yield, strong profitability, and a cheap valuation is rare and is the core reason why the stock passes the Best Dividend screen's filters.
Analyst Views and Future Growth
While the dividend story looks strong on historical and current data, future growth is a moderate concern. The overall ChartMill Growth Rating is a weaker 4 out of 10. Revenue actually decreased by -2.73% over the last year. However, the future outlook is more promising.
- EPS Growth (Past 5 years): 9.50% per year.
- EPS Growth (Expected future): 9.99% per year.
- Revenue Growth (Expected future): 3.93% per year.
The future growth is expected to be stable for earnings, and the revenue growth is actually forecast to accelerate compared to the recent past. For the dividend investor, the key question is whether this future growth will be sufficient to close the gap with the current 10.47% dividend growth rate. If earnings grow as expected, the payout ratio will stabilize, making the dividend more sustainable. This is a crucial area to monitor, but the cheap valuation already prices in some of these risks.
A Final Word on the Strategy
Amdocs is a textbook example of what our Best Dividend screen is designed to find. It offers a very attractive yield backed by a solid track record of growth and payments. The valuation is compellingly cheap, providing a buffer, and the company is fundamentally profitable with healthy cash flows. The main risks—a slightly elevated payout ratio and some liquidity metrics—are manageable given the company's strong solvency and cash generation.
The screen has done its job of narrowing down the field. Now it's up to you to perform the detailed analysis.
Looking for more ideas that match this profile? You can run the same screen and explore additional results by visiting our Best Dividend Stocks Screener. The full fundamental report for Amdocs is also available here for a deeper analysis.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always conduct your own research and consider your financial situation before making any investment decisions. Past performance is not indicative of future results.
Read full article here »
View the Zacks #1 Rank List
Amdocs Ltd (NASDAQ:DOX) Screens as a Best Dividend Stock with Attractive Valuation and High Yield
After an initial run of our Best Dividend Stocks screener, designed to surface quality names that can sustain a healthy payout, Amdocs Ltd (NASDAQ:DOX) emerges as a strong candidate. The strategy behind this screen is to avoid the trap of chasing the highest dividend yield without considering the fundamentals. By filtering for a minimum ChartMill Dividend Rating of 7, while also requiring a Health Rating of 5 and a Profitability Rating of 5, we aim to find companies that not only pay a generous dividend but also have the financial stability to keep doing so. The goal is to sidestep value traps where a high yield is merely a symptom of a plunging stock price. Amdocs not only clears these hurdles but stands out in several key areas, particularly its valuation, which makes the high dividend yield even more attractive.
Dividend Profile: High Yield with a Track Record
The most immediate draw for a dividend investor is the yield itself. Amdocs provides a yearly dividend yield of 4.42%, which is significantly higher than the S&P 500 average of 1.83% and an industry average of 1.68%. In fact, it pays more than 90.91% of its peers in the IT Services industry. However, as our screening methodology emphasizes, a high yield requires deeper investigation.
The screen's criteria for a minimum Dividend Rating of 7 ensures we look beyond a simple snapshot. Amdocs earns a top-tier Dividend Rating of 8 out of 10, supported by a strong history. The company has been paying a dividend for at least 10 years and has not reduced it in that time. Furthermore, the dividend has been growing at an annual rate of 10.47%, a strong signal of management's confidence in the company's cash generation capabilities.
However, no dividend is without its risks. The payout ratio stands at 43.06% of net income. While this is not alarming, it is on the higher side. More importantly, the report notes that the dividend is growing faster than earnings, which is a clear red flag for long-term sustainability. This is a key aspect our screening methodology flags for further investor scrutiny. A current yield that looks cheap due to a stock price decline (-20.61% in the last three months) also warrants a closer look at the underlying business health.
Profitability and Health: The Supporting Cast
The screen's filters for decent profitability (Rating >= 5) and health (Rating >= 5) are crucial to support the dividend story. A high yield is meaningless if the company is losing money or taking on too much debt to pay shareholders.
Valuation: The Strong Case for Value and Yield
What truly sets Amdocs apart is its valuation, which is where the strategy against chasing yield in a falling market becomes most relevant. The stock appears significantly undervalued on a pure earnings basis.
For a dividend investor, this valuation is a strong double-edged sword. It suggests that the high yield (4.42%) is not solely due to a recent price crash, but rather that the stock was already trading at a depressed valuation. This provides a margin of safety, as the yield can remain attractive even if the price stabilizes or recovers. The strong profitability rating (8/10) partially explains the market's skepticism might be overdone, as the report notes, "An outstanding profitability rating, which may justify a higher PE ratio." This combination of a high dividend yield, strong profitability, and a cheap valuation is rare and is the core reason why the stock passes the Best Dividend screen's filters.
Analyst Views and Future Growth
While the dividend story looks strong on historical and current data, future growth is a moderate concern. The overall ChartMill Growth Rating is a weaker 4 out of 10. Revenue actually decreased by -2.73% over the last year. However, the future outlook is more promising.
The future growth is expected to be stable for earnings, and the revenue growth is actually forecast to accelerate compared to the recent past. For the dividend investor, the key question is whether this future growth will be sufficient to close the gap with the current 10.47% dividend growth rate. If earnings grow as expected, the payout ratio will stabilize, making the dividend more sustainable. This is a crucial area to monitor, but the cheap valuation already prices in some of these risks.
A Final Word on the Strategy
Amdocs is a textbook example of what our Best Dividend screen is designed to find. It offers a very attractive yield backed by a solid track record of growth and payments. The valuation is compellingly cheap, providing a buffer, and the company is fundamentally profitable with healthy cash flows. The main risks—a slightly elevated payout ratio and some liquidity metrics—are manageable given the company's strong solvency and cash generation.
The screen has done its job of narrowing down the field. Now it's up to you to perform the detailed analysis.
Looking for more ideas that match this profile? You can run the same screen and explore additional results by visiting our Best Dividend Stocks Screener. The full fundamental report for Amdocs is also available here for a deeper analysis.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always conduct your own research and consider your financial situation before making any investment decisions. Past performance is not indicative of future results.
Read full article here »